Current trends in the development of nitric oxide donors - PubMed (original) (raw)
Affiliations
- PMID: 10390607
Review
Current trends in the development of nitric oxide donors
Y C Hou et al. Curr Pharm Des. 1999 Jun.
Abstract
Nitric oxide (NO) is an important messenger molecule involved in many pathological and physiological processes within the mammalian body. Exogenous NO sources constitute a powerful way to supplement NO when the body can not generate enough for normal biological functions. In this article, general aspects on NO and NO donors are reviewed. Major focus is placed on recent developments of novel NO donors, NO releasing device(s) as well as innovative improvements to current NO donors. Finally, an outlook on future NO donor development is provided.
Similar articles
- Nitric-oxide releasing molecules: a new class of drugs with several major indications.
Burgaud JL, Riffaud JP, Del Soldato P. Burgaud JL, et al. Curr Pharm Des. 2002;8(3):201-13. doi: 10.2174/1381612023396357. Curr Pharm Des. 2002. PMID: 11864065 Review. - Nitric oxide-releasing drugs: a novel class of effective and safe therapeutic agents.
Burgaud JL, Ongini E, Del Soldato P. Burgaud JL, et al. Ann N Y Acad Sci. 2002 May;962:360-71. doi: 10.1111/j.1749-6632.2002.tb04080.x. Ann N Y Acad Sci. 2002. PMID: 12076987 Review. - Nitric oxide donor drugs: current status and future trends.
Megson IL, Webb DJ. Megson IL, et al. Expert Opin Investig Drugs. 2002 May;11(5):587-601. doi: 10.1517/13543784.11.5.587. Expert Opin Investig Drugs. 2002. PMID: 11996642 Review. - Nitric oxide-donating materials and their potential in pharmacological applications for site-specific nitric oxide delivery.
Eroy-Reveles AA, Mascharak PK. Eroy-Reveles AA, et al. Future Med Chem. 2009 Nov;1(8):1497-507. doi: 10.4155/fmc.09.111. Future Med Chem. 2009. PMID: 21426062 Review. - Recent Developments in Drug Design of NO-donor Hybrid Compounds.
Sharma R, Joubert J, Malan SF. Sharma R, et al. Mini Rev Med Chem. 2018;18(14):1175-1198. doi: 10.2174/1389557518666180416150005. Mini Rev Med Chem. 2018. PMID: 29663881 Review.
Cited by
- Effect of phlorotannins isolated from Ecklonia cava on angiotensin I-converting enzyme (ACE) inhibitory activity.
Wijesinghe WA, Ko SC, Jeon YJ. Wijesinghe WA, et al. Nutr Res Pract. 2011 Apr;5(2):93-100. doi: 10.4162/nrp.2011.5.2.93. Epub 2011 Apr 23. Nutr Res Pract. 2011. PMID: 21556221 Free PMC article. - Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications.
Casas AI, Dao VT, Daiber A, Maghzal GJ, Di Lisa F, Kaludercic N, Leach S, Cuadrado A, Jaquet V, Seredenina T, Krause KH, López MG, Stocker R, Ghezzi P, Schmidt HH. Casas AI, et al. Antioxid Redox Signal. 2015 Nov 10;23(14):1171-85. doi: 10.1089/ars.2015.6433. Antioxid Redox Signal. 2015. PMID: 26583264 Free PMC article. Review. - A possible mechanism for the apocynin-induced nitric oxide accumulation in plants.
Tossi V, Lamattina L, Cassia R. Tossi V, et al. Plant Signal Behav. 2009 Sep;4(9):880-2. doi: 10.4161/psb.4.9.9429. Epub 2009 Sep 3. Plant Signal Behav. 2009. PMID: 19847121 Free PMC article. - Nitric oxide compounds have different effects profiles on human articular chondrocyte metabolism.
de Andrés MC, Maneiro E, Martín MA, Arenas J, Blanco FJ. de Andrés MC, et al. Arthritis Res Ther. 2013;15(5):R115. doi: 10.1186/ar4295. Arthritis Res Ther. 2013. PMID: 24025112 Free PMC article. - Liquid-infused nitric oxide-releasing (LINORel) silicone for decreased fouling, thrombosis, and infection of medical devices.
Goudie MJ, Pant J, Handa H. Goudie MJ, et al. Sci Rep. 2017 Oct 19;7(1):13623. doi: 10.1038/s41598-017-14012-9. Sci Rep. 2017. PMID: 29051609 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources